Jennison Associates’s Fibrocell Science Inc. FCSC Stock Holding History

Jennison Associates’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-127,512	Closed	-$4.78M	–	673
2016 Q1	$4.78M	Sell	127,512 -60,290	-32%	-$2.41M	0.01%	492
2015 Q4	$12.8M	Buy	187,802 +605	+0.3%	+$43.5K	0.01%	468
2015 Q3	$10.8M	Buy	187,197 +10,195	+6%	+$902K	0.01%	505
2015 Q2	$14M	Buy	177,002 +1,154	+0.7%	+$77.7K	0.01%	496
2015 Q1	$11.9M	Sell	175,848 -2,798	-2%	-$180K	0.01%	489
2014 Q4	$6.86M	Sell	178,646 -5,674	-3%	-$229K	0.01%	498
2014 Q3	$8.02M	Buy	184,320 +169	+0.1%	+$7.91K	0.01%	491
2014 Q2	$11M	Sell	184,151 -13,139	-7%	-$733K	0.01%	472
2014 Q1	$15.5M	Buy	197,290 +1,091	+0.6%	+$84.6K	0.01%	462
2013 Q4	$11.9M	Buy	196,199 +2,248	+1%	+$131K	0.01%	479
2013 Q3	$12.7M	Buy	+193,951	New	+$15.7M	0.01%	466

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates's FCSC Position: Q2 2016 in Review

Jennison Associates sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 127,512 shares — an estimated $4.78M sold.

Jennison Associates first reported a position in FCSC in Q3 2013 and held it in 11 quarters. The position peaked at $15.5M in Q1 2014. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

Jennison Associates reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
Jennison Associates sold 127,512 Fibrocell Science Inc. shares in Q2 2016, an estimated $4.78M.
Jennison Associates first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 11 quarters.
Jennison Associates's Fibrocell Science Inc. position peaked at $15.5M in Q1 2014.
44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.